Key result
Preoperative F-18 FDG PET (maximum SUV 5.6) was useful for confirming the malignancy of a huge intracardiac angiosarcoma and exploring distant metastases in a 60-year-old woman.
Why the study?
Does preoperative FDG PET help confirm malignancy and determine surgical indication in patients with huge intracardiac tumors?
Case Report (n=1)
Does preoperative FDG PET help confirm malignancy and determine surgical indication in patients with huge intracardiac tumors?
Preoperative FDG PET is useful for assessing the malignant potential and distant metastases of large intracardiac tumors to guide surgical decision-making.
No takes yet. Share an insight, caveat, or question.
May guide surgical decisions for rare intracardiac masses; hypothesis-generating and leaves broader adoption open pending validation.
Higashiyama et al. (2009) conducted a case report in Intracardiac angiosarcoma (n=1). F-18 fluorodeoxyglucose (FDG) PET was evaluated on Confirmation of malignancy and distant metastases. Preoperative F-18 FDG PET (maximum SUV 5.6) was useful for confirming the malignancy of a huge intracardiac angiosarcoma and exploring distant metastases in a 60-year-old woman.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: